Learn more

CEDARS-SINAI MEDICAL CENTER

Overview
  • Total Patents
    212
  • GoodIP Patent Rank
    7,642
  • Filing trend
    ⇩ 88.0%
About

CEDARS-SINAI MEDICAL CENTER has a total of 212 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CEDARS SINAI MEDICAL CENTER, TIANJIN MEDICAL UNIV GENERAL HOSPITAL and UNIV RUSH MEDICAL CENTER.

Patent filings per year

Chart showing CEDARS-SINAI MEDICAL CENTERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pimentel Mark 30
#2 Black Keith L 18
#3 Chang Christopher 17
#4 Targan Stephan R 16
#5 Mcgovern Dermot P 11
#6 Marban Eduardo 10
#7 Svendsen Clive 9
#8 Mathur Ruchi 8
#9 Butte Pramod 8
#10 Al-Jilaihawi Hasanian 8

Latest patents

Publication Filing date Title
WO2020172188A1 Systems and methods for calcium-free computed tomography angiography
WO2020163713A1 Methods, systems, and kits for treating inflammatory disease targeting skap2
WO2020163715A1 Methods, systems, and kits for treating inflammatory disease targeting il18r1
WO2020163783A1 Methods for accurate needle-free assessment of myocardial oxygenation
WO2020160307A1 Method for processing and analysis of viscous liquid biological samples
WO2017210652A1 Cdc-derived exosomes for treatment of ventricular tachyarrythmias
WO2017210645A1 Visual stimuli maze test for detecting visual abnormalities in prodromal alzheimer's disease and in alzheimer's disease
WO2017210488A1 B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment
WO2017193008A1 Methods of diagnosing and treating cancer with micrornas
TW201737864A Tissue classification method using time-resolved fluorescence spectroscopy and combination of monopolar and bipolar cortical and subcortical stimulator with time-resolved fluorescence spectroscopy
US2017174760A1 Method for treating antibody-mediated rejection post-transplantation
WO2017151674A1 Method of endogenous stem cell activation for tendon/ligament osseointegration
US2017240965A1 Methods for prognosing heart transplant
WO2017136844A1 Methods for predicting risk of antibody-mediated rejection
WO2017123662A1 Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017100722A1 Methods for treating nephrotic syndrome
WO2017079632A1 Patient-derived ctc-xenograft models
WO2017051402A2 A method effective to modulate expression of t-box protein 4 (tbx4) for reducing progression of lung fibrosis after a lung injury
US2017044615A1 METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (mrUC) REQUIRING COLECTOMY
US2017112897A1 Methods for treating brain insulin resistance